Summary
In this review of the literature data are collected from the more recent studies on the susceptibility ofBordetella pertussis to penicillins, cephalosporins, other beta-lactam antibiotics, aminoglycosides, tetracyclines, erythromycin, josamycin, co-trimoxazole and various other antibiotics. The methods of susceptibility testing ofB. pertussis are discussed and suggestions for standardization are made.
Zusammenfassung
In dieser Literatur-Übersicht werden Daten aus neueren Arbeiten zusammengestellt über die Empfindlichkeit vonBordetella pertussis gegen Penicilline, Cephalosporine, andere Beta-Laktam-Antibiotika, Aminoglykoside, Tetrazykline, Erythromycin, Josamycin, Co-trimoxazol und verschiedene andere Antibiotika. Die Verfahren zur Empfindlichkeitstestung vonB. pertussis werden diskutiert, und es werden Vorschläge für eine Standardisierung gemacht.
This is a preview of subscription content, access via your institution.
Literature
Bass, J. W., Crast, F. W., Kotheimer, J. B., Mitchell, I. A. Susceptibility ofBordetella pertussis to nine antimicrobial agents. Amer. J. Dis. Child. 117 (1969) 276–280.
Zackrisson, G., Brorson, J. E., Trollfors, B. Influence of culture medium and inoculum size on susceptibility ofBordetella pertussis to antibacterial agentsin vitro. Eur. J. Clin. Microbiol. 3 (1984) 566–567.
Zackrisson, G., Brorson, J. E., Björnegard, B., Trollfors, B. Susceptibility ofBordetella pertussis to doxycycline, cinoxacin, nalidixic acid, norfloxacin, imipenem, mecillinam and rifampicin. J. Antimicrob. Chemother. 15 (1985) 629–632.
Field, L. H., Parker, C. D. Antibiotic susceptibility testing ofBordetella pertussis. Am. J. Clin. Pathol. 74 (1980) 312–316.
Janovská, D., Výmola, F.: Epidemiological surveillance of antibiotic sensitivity inBordetella pertussis andparapertussis in Czechoslovakia. In:Hejzlar, M., Semonsky, M., Masak, S. (eds.): Advances in antimicrobial and antineoplastic chemotherapy, Vol. I/1 (1972) 643–644.
Zackrisson, G., Brorson, J. E., Krantz, I., Trollfors, B. In-vitro sensitivity ofBordetella pertussis. J. Antimicrob. Chemother. 11 (1983) 407–411.
Shishido, H., Matsumoto, K., Watanabe, K., Uzuka, Y. In vitro activity of beta-lactam antibiotics againstBordetella pertussis: unusually high anti-B. pertussis activity of piperazine betalactams. Curr. Chemother. Infect. Dis. 1 (1980) 84–87.
Bannatyne, R. M., Cheung, R. Antimicrobial susceptibility ofBordetella pertussis strains isolated from 1960 to 1981. Antimicrob. Agents Chemother. 21 (1982) 666–667.
Bannatyne, R. M., Cheung, R. Susceptibility ofBordetella pertussis to cephalosporin derivatives and imipenem. Antimicrob. Agents Chemother. 26 (1984) 604–605.
Hoppe, J. E., Haug, A., Botzenhart, K. Susceptibility ofBordetella pertussis andBordetella parapertussis to twenty-four antibiotics. Chemotherapy 33 (1987) 250–254.
Hoppe, J. E., Haug, A., Botzenhart, K.: Bordetellae and charcoal horse blood agar: inactivation of antibiotics in agar during prolonged incubation for susceptibility testing. Chemotherapy 34 (1988) (in press).
Hoppe, J. E., Haug, A.: Treatment and prevention of pertussis by antimicrobial agents. Infection 16 (1988) (in press).
Stauffer, L. R., Brown, D. R., Sandstrom, R. E. Cephalexin-supplemented Jones-Kendrick charcoal agar for selective isolation ofBordetella pertussis: Comparison with previously described media. J. Clin. Microbiol. 17 (1983) 60–62.
Watanabe, M., Sekiya, K., Nakase, Y., Yamada, M. Drug susceptibility ofBordetella pertussis andBordetella parapertussis. Jap. J. Bact. 30 (1975) 501–505.
Simon, C., Bontemps, M., Wiese, K., Schewior-Roland, R. Zur Ampicillin-Therapie des Keuchhustens. Dtsch. Med. Wochenschr. 94 (1969) 2435–2437.
Simon, C., Junk, W., Malerczyk, U. Azidocillin. Arzneim.-Forsch. (Drug Res.) 26 (1976) 424–427.
Neu, H. C. Antimicrobial activity and human pharmacology of amoxicillin. J. Infect. Dis. 129 (1974) S123-S131.
Sutcliffe, E. M., Abbott, J. D. Selective medium for the isolation ofBordetella pertussis andparapertussis. J. Clin. path. 25 (1972) 732–733.
Bass, J. W. Erythromycin for treatment and prevention of pertussis. Pediatr. Infect. Dis. 5 (1986) 154–157.
Wildfeuer, A., Schmalreck, A. F., Vanek, E. Wirksamkeit von Josamycin gegen Bakterienin vitro. Med. Welt 36 (1985) 777–780.
Di Nola, F., Bramato, C. Pharmacokinetics and clinical utilization of a new macrolide, josamycin. Drugs Exptl. Clin. Res. 8 (1982) 309–311.
Bushby, S. R. M. Trimethoprim-sulfamethoxazole:in vitro microbiological aspects. J. Infect. Dis. 128 (1973) S443-S462.
Darrell, J. H., Garrod, L. P., Waterworth, P. M. Trimethoprim: Laboratory and clinical studies. J. Clin. Path. 21 (1968) 202–209.
Washington II, J. A. Susceptibility tests: agar dilution. In:Lennette, E. H., Balows, A., Hausler, W. J., Shadomy, H. J. (eds.): Manual of Clinical Microbiology. American Society for Microbiology, Washington, DC 1985, pp. 967–971.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Hoppe, J.E., Haug, A. Antimicrobial susceptibility of bordetella pertussis (Part I). Infection 16, 126–130 (1988). https://doi.org/10.1007/BF01644321
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01644321